A Review of Antimicrobial Agents for Chronic Wounds with Infection
Abbas Hallaj Karladani*
Department of Cityortopeden, Skåne Region, Sweden
*Corresponding Author: Abbas Hallaj Karladani, Department of Cityortopeden, Skåne Region, Sweden.
Received:
September 25, 2023; Published: October 11, 2023
Abstract
Given the rising threat of antibiotic resistance worldwide, it is crucial to explore alternatives or complementary treatments to antibiotics. Wound care is a significant aspect of emergency care, day clinics, and elderly care. Managing chronic ulcers, such as diabetic foot ulcers and leg ulcers, often incurs high costs [1]. Many patients with wound colonization automatically receive antibiotics [2]. However, alternative therapies have shown potential to significantly reduce the need for antibiotic treatment, as indicated by results from the Swedish National Quality Register for chronic ulcers [3].
Keywords: Antimicrobial Agents; Chronic Wounds; Infection
References
- Edmonds M. “Body of knowledge around the diabetic foot and limb salvage”. The Journal of Cardiovascular Surgery (Torino) 53 (2012): 605-616.
- Oien RF and Akesson N. “Bacterial cultures, rapid strep test, and antibiotic treatment in infected hard-to-heal ulcers in primary care”. Scandinavian Journal of Primary Health Care 4 (2012): 254-258.
- Rikssår, www.rikssar.se
- Andriessen A and Eberlein TH. “Assessment of a wound cleansing solution in the treatment of problem wounds”. Wounds6 (2008): 171-175.
- Kaehn K and Eberlein T. “Polyhexanide (PHMB) and Betaine in wound care management”. EWMA Journal 2 (2008): 13-17.
- Dissemond J., et al. “Practice oriented expert recommendation for the treatment of critically colonised and locally infected wounds using polyhexanide”. Journal of Tissue Viability 19 (2010): 106-115.
- Percival SL., et al. “Bacterial resistance to silver in wound care”. Journal of Hospital Infection 1 (2005): 1-7.
- S Gilliver. “A well-tolerated antiseptic with no reported toxic effects”. Journal of Wound Care/Active Health Care - PHMB: Supplement (2009).
- Bidgoli SA., et al. “Toxicity assessment of nanosilver wound dressing in Wistar rat”. Acta Medica Iranica 4 (2013): 203-208.
- Eberlein T., et al. “Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds”. Journal of Wound Care1 (2012): 12-20.
- Steven L Percival., et al. “Biofilms and Wounds: An Overview of the Evidence.
- Hansmann F., et al. “Ophthalmologe. Polyhexamethylbiguanid (PHMB) as preoperative antiseptic for cataract surgery]” 4 (2004): 377-383.
- Mueller SW and Krebsbach LE. ”Impaa of an antimicrobial-impregnated gauze dressing on surreal site infections including methicillin-resistant Staphylococcus aureus infections”. American Journal of Infection Control 9 (2008): 651-655.
- Mulder GD., et al. “Polyhexamethylene biguanide (PHMB): an addendum to current topical antimicrobials”. Wounds 19:7 (2007): 173-182.
- Beneke MJ and Doner J. “Observation of nosocomial surgicai-site infection rates with utilization ‘of antimicrobial gauze dressing in an acute care setting. Abstract presented at the 18th Annual Symposium on Advanced Wound Care, San Diego (2005).
- Penn RG., et al. “The reduction of vascular surreal site infections the use of antimicrobial gauze dressing.
- , et al. “Biocidal composition and methods of using the same, US patent US 2013/0150451 A1.
- Finnegan S Percival SL. “EDTA: An Antimicrobial and Antibiofilm Agent for Use in Wound Care”. Advances in Wound Care (New Rochelle)7 (2015): 415-421.
- Paydar B Ziaeian., et al. “A Comparison of the Effects of Topical Prolavacid Solution (a Polyhexamethylene Biguanide-Based Wound Cleanser) and Medihoney Ointment in a Rat Model of Cutaneous Wound”. Advances in Wound Care 12 (2017): 407-12.
Citation
Copyright